{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:24:07Z","timestamp":1786991047217,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000073"],"award-info":[{"award-number":["82000073"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82,070,060"],"award-info":[{"award-number":["82,070,060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.intimp.2021.108129","type":"journal-article","created":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T22:43:40Z","timestamp":1632091420000},"page":"108129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Nintedanib ameliorates imiquimod-induced psoriasis in mice by inhibiting NF-\u03baB and VEGFR2 signaling"],"prefix":"10.1016","volume":"100","author":[{"given":"Xiaohe","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buri","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenguo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honggang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2021.108129_b0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.intimp.2021.108129_b0010","unstructured":"World Health Organization, Global report on psoriasis, 2016. https:\/\/apps.who.int\/iris\/handle\/10665\/204417. (Accessed April 29 2021)."},{"issue":"3","key":"10.1016\/j.intimp.2021.108129_b0015","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jaad.2013.11.013","article-title":"Psoriasis prevalence among adults in the United States","volume":"70","author":"Rachakonda","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"issue":"9997","key":"10.1016\/j.intimp.2021.108129_b0020","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2021.108129_b0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.det.2014.09.004","article-title":"Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities","volume":"33","author":"Ryan","year":"2015","journal-title":"Dermatol. Clin."},{"issue":"6","key":"10.1016\/j.intimp.2021.108129_b0030","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.bcp.2004.05.039","article-title":"Regulation at multiple levels of NF-kappaB-mediated transactivation by protein acetylation","volume":"68","author":"Quivy","year":"2004","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2021.108129_b0035","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.0022-202X.2005.23735.x","article-title":"Differential Expression of Phosphorylated NF-\u03baB\/RelA in Normal and Psoriatic Epidermis and Downregulation of NF-\u03baB in Response to Treatment with Etanercept","volume":"124","author":"Lizzul","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2021.108129_b0040","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/ijd.12050","article-title":"Role of NF-jB in the pathogenesis of psoriasis elucidated by its staining in skin biopsy specimens","volume":"53","author":"Moorchung","year":"2014","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.intimp.2021.108129_b0045","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.cb.10.110194.002201","article-title":"Sructure, regulation and function of NF-\u03baB","volume":"10","author":"Siebenlist","year":"1994","journal-title":"Annu. Rev. Cell Biol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108129_b0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jdermsci.2010.03.023","article-title":"Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis\u2013a possible target for novel therapies?","volume":"58","author":"Canavese","year":"2010","journal-title":"J. Dermatol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2021.108129_b0055","doi-asserted-by":"crossref","first-page":"632","DOI":"10.4103\/0019-5154.143574","article-title":"Remission of psoriasis and psoriatic arthritis during bevacizumab therapy for renal cell cancer","volume":"59","author":"Raychaudhuri","year":"2014","journal-title":"Indian J. Dermatol."},{"issue":"6","key":"10.1016\/j.intimp.2021.108129_b0060","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.immuni.2013.11.011","article-title":"S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3","volume":"39","author":"Schonthaler","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2021.108129_b0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2353\/ajpath.2008.071074","article-title":"Inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor","volume":"173","author":"Halin","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108129_b0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/blood-2002-12-3793","article-title":"Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis","volume":"102","author":"Xia","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.intimp.2021.108129_b0075","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1183\/09031936.00174914","article-title":"Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis","volume":"45","author":"Wollin","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.intimp.2021.108129_b0080","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1136\/annrheumdis-2016-210823","article-title":"Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis","volume":"76","author":"Huang","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2021.108129_b0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1124\/jpet.113.208223","article-title":"Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis","volume":"349","author":"Wollin","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2021.108129_b0090","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10456-017-9543-z","article-title":"Effects of nintedanib on the microvascular architecture in a lung fibrosis model","volume":"20","author":"Ackermann","year":"2017","journal-title":"Angiogenesis"},{"issue":"4","key":"10.1016\/j.intimp.2021.108129_b0095","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1111\/1346-8138.14641","article-title":"Remission of psoriasis with nintedanib for the treatment of idiopathic pulmonary fibrosis","volume":"46","author":"Murata","year":"2019","journal-title":"J. Dermatol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108129_b0100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.trsl.2007.01.003","article-title":"SU-011248, a vascular endothelial growth factor receptor-tyrosine kinase inhibitor, controls chronic psoriasis","volume":"149","author":"Keshtgarpour","year":"2007","journal-title":"Transl. Res."},{"issue":"6","key":"10.1016\/j.intimp.2021.108129_b0105","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/MAJ.0b013e3181dd1aa5","article-title":"Improvement of psoriasis during sunitinib therapy for renal cell carcinoma","volume":"339","author":"Narayanan","year":"2010","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.intimp.2021.108129_b0110","doi-asserted-by":"crossref","unstructured":"M. S, F. H, K. S, Improvement of psoriasis during imatinib therapy in a patient with a metastatic gastrointestinal stromal tumour, Br. J. Dermatol. 147 (2002) 385\u2013410.","DOI":"10.1046\/j.1365-2133.2002.497217.x"},{"key":"10.1016\/j.intimp.2021.108129_b0115","first-page":"496","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"New J. Med."},{"issue":"18","key":"10.1016\/j.intimp.2021.108129_b0120","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMra041320","article-title":"Psoriasis","volume":"352","author":"Sch\u00f6n","year":"2005","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.intimp.2021.108129_b0125","doi-asserted-by":"crossref","unstructured":"L. van der Fits, S. Mourits, J.S. Voerman, M. Kant, L. Boon, J.D. Laman, F. Cornelissen, A.M. Mus, E. Florencia, E.P. Prens, E. Lubberts, Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis, J. Immunol. 182(9) (2009) 5836\u201345.","DOI":"10.4049\/jimmunol.0802999"},{"key":"10.1016\/j.intimp.2021.108129_b0130","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/bjd.13236","article-title":"Aldara-induced skin inflammation - studies of psoriasis patients","volume":"172","author":"Vinter","year":"2015","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.intimp.2021.108129_b0135","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3892\/mmr.2014.2136","article-title":"Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17\/IL-23 axis","volume":"9","author":"Qin","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2021.108129_b0140","doi-asserted-by":"crossref","unstructured":"R.P. Nair, K.C. Duffin, C. Helms, J. Ding, P.E. Stuart, D. Goldgar, J.E. Gudjonsson, Y. Li, T. Tejasvi, B.J. Feng, A. Ruether, S. Schreiber, M. Weichenthal, D. Gladman, P. Rahman, S.J. Schrodi, S. Prahalad, S.L. Guthery, J. Fischer, W. Liao, P.Y. Kwok, A. Menter, G.M. Lathrop, C.A. Wise, A.B. Begovich, J.J. Voorhees, J.T. Elder, G.G. Krueger, A.M. Bowcock, G.R. Abecasis, P. Collaborative Association Study of, Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways, Nat. Genet. 41(2) (2009) 199\u2013204.","DOI":"10.1038\/ng.311"},{"issue":"6","key":"10.1016\/j.intimp.2021.108129_b0145","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis Pathogenesis and Treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2021.108129_b0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jdermsci.2012.11.002","article-title":"NF-kappaB: an essential transcription factor in psoriasis","volume":"69","author":"Goldminz","year":"2013","journal-title":"J. Dermatol. Sci."},{"issue":"16","key":"10.1016\/j.intimp.2021.108129_b0155","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1042\/CS20170134","article-title":"Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease","volume":"131","author":"Liu","year":"2017","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.intimp.2021.108129_b0160","doi-asserted-by":"crossref","unstructured":"F. Liu, C. Yu, H. Qin, S. Zhang, L. Fang, Y. Wang, J. Wang, B. Cui, S. Hu, N. Liu, S. Zhuang, Nintedanib attenuates peritoneal fibrosis by inhibiting mesothelial-to-mesenchymal transition, inflammation and angiogenesis, J. Cell Mol. Med. (2021).","DOI":"10.1111\/jcmm.16518"},{"key":"10.1016\/j.intimp.2021.108129_b0165","doi-asserted-by":"crossref","unstructured":"X. Liu, Y. Cheng, X. Chen, J. Yang, L. Xu, C. Zhang, MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2, J. Biol. Chem. 286(49) (2011) 42371\u201342380.","DOI":"10.1074\/jbc.M111.261065"},{"issue":"16","key":"10.1016\/j.intimp.2021.108129_b0170","doi-asserted-by":"crossref","first-page":"14410","DOI":"10.1074\/jbc.M111.228130","article-title":"Double anti-angiogenic and anti-inflammatory protein Valpha targeting VEGF-A and TNF-alpha in retinopathy and psoriasis","volume":"286","author":"Jung","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2021.108129_b0175","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1182\/blood-2003-08-2964","article-title":"Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia","volume":"104","author":"Kunstfeld","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2021.108129_b0180","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1084\/jem.180.3.1141","article-title":"Overexpression of vascular permeability factor\/vascular endothelial growth factor and its receptors in psoriasis","volume":"180","author":"Detmar","year":"1994","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.intimp.2021.108129_b0185","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.138.6.791","article-title":"Mediation of Systemic Vascular Hyperpermeability in Severe Psoriasis by Circulating Vascular Endothelial Growth Factor","volume":"138","author":"Creamer","year":"2002","journal-title":"Arch. Dermatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921007657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921007657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:28:53Z","timestamp":1761586133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921007657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":37,"alternative-id":["S1567576921007657"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108129","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nintedanib ameliorates imiquimod-induced psoriasis in mice by inhibiting NF-\u03baB and VEGFR2 signaling","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108129"}}